Projected annual CH₄ (A) and N₂O (B) emissions (Mt/yr) by 2050, based on FAO no-mitigation (increasing) and mitigation (decreasing) scenarios, and on a consta... by Fabio Correddu (12501799)

Probabilistic results of the incremental cost-effectiveness pairwise between various treatments with NVBP for a simulation of 100,000 iterations. by Yi Lin (49406)

Plot showing stages of IPIs recorded from the completed drinking bouts by all bats. by Laura N. Kloepper (8173881)

Loss of RBM-26 function causes a reduction in the density of mitochondria in the PLM axon. by Tamjid A. Chowdhury (14149846)

Triiodothyroacetic acid (TRIAC), thyroxine (T4) and 3,5,3’-triiodothyronine (T3) levels in plasma of vehicle treated wild type (Wt; TRIAC n = 5; T4 n = 5; T3 n = 5 and TSH n = 4) a... by Soledad Bárez-López (607514)

2‑Ethylhexyl Diphenyl Phosphate and Its Hydroxylated Metabolites are Anti-androgenic and Cause Adverse Reproductive Outcomes in Male Japanese Medaka (Oryzias latipes) by Yu Li (183836)

“…The AR antagonistic activity of EHDPP and its metabolites must therefore play a key role in intersex incidence. EHDPP also significantly (<i>p</i> < 0.05) repressed reproductive behaviors of males in the 434 ng/L group and decreased fertility in high-exposure groups compared with the control. …”

2‑Ethylhexyl Diphenyl Phosphate and Its Hydroxylated Metabolites are Anti-androgenic and Cause Adverse Reproductive Outcomes in Male Japanese Medaka (Oryzias latipes) by Yu Li (183836)

“…The AR antagonistic activity of EHDPP and its metabolites must therefore play a key role in intersex incidence. EHDPP also significantly (<i>p</i> < 0.05) repressed reproductive behaviors of males in the 434 ng/L group and decreased fertility in high-exposure groups compared with the control. …”

Nicotine decreased Akt phosphorylation in SK-BR-3 cells. by Masanori A. Murayama (5774585)

Age- and sex- specific median yearly incidence (A) and mortality (B) rate of liver cancer per 10⁶ population over 2014–2023. by Ayana Ablayeva (22103708)

MVEC viability is decreased over time in PEG-based hydrogels. by Rebecca A. Scott (488956)

Correlations between the concentrations of p24 (ng/mL) and the relative expression of viral restriction factors in infected CD4+ T cells. by Natalia Alvarez (5159594)

Relationship between mean SaFi at admission and clinical outcome at 60 days. by Ismael Francisco Aomar-Millán (14838595)

Subjects:

Global number of meningitis deaths by etiology and age group in 1990(A) and 2021(B). by Jun Li (6494)

Effects of melatonin on the TGF-β1/Smad pathway and EMT in a PS/LPS-induced bladder fibrosis model in rats. by Yang Zhang (30734)

Mean values and 95% confidence intervals for resting flow, arterial occlusion pressure (AOP), biological zero, reactive hyperemia (RHmax), and time to peak across the three conditi... by Robert Trybulski (10998702)

Treatment with FTY720 induces a decrease in inactive (phosphorylated) SAMHD1. by Rachel S. Resop (9238645)

Patterns of lifetime use of substances by gender. by Daniel Waiganjo Kinyanjui (15877725)

“…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”

S1 Data - by Daniel Waiganjo Kinyanjui (15877725)

“…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”

Factors associated with substance use. by Daniel Waiganjo Kinyanjui (15877725)

“…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”

Factors associated with personality traits. by Daniel Waiganjo Kinyanjui (15877725)

“…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”